The effectiveness of early anticoagulant treatment in Covid-19 patients

Yakup Arslan1, Gulden Yilmaz2, Deniz Dogan1

  • 1Department of Pulmonology, Gulhane Education and Research Hospital, University of Health Sciences, Ankara, Turkey.

Phlebology
|November 27, 2020
PubMed

Insights

Early anticoagulant treatment with Low Molecular Weight Heparin (LMWH) in hospitalized COVID-19 patients showed improved outcomes. LMWH use was associated with reduced intensive care unit transfers and shorter hospital stays, suggesting clinical benefits.

Area of Science:

  • Medical Research
  • Infectious Diseases
  • Pharmacology

Background:

  • COVID-19 is a rapidly spreading infectious disease.
  • Thrombosis can worsen COVID-19 outcomes.
  • Early intervention is crucial for managing severe infections.

Purpose of the Study:

  • To evaluate the impact of early anticoagulant therapy in hospitalized COVID-19 patients.
  • To compare outcomes between patients treated with and without Low Molecular Weight Heparin (LMWH).

Main Methods:

  • Retrospective comparative cohort study of 413 hospitalized COVID-19 patients.
  • Treatment groups: LMWH (n=187) vs. no LMWH (n=226).
  • Data collected before and after an updated treatment guide in April 2020.

Main Results:

  • LMWH-treated patients had higher d-dimer and platelet counts.
  • LMWH-untreated patients showed increased inflammatory markers (ferritin, IL-6, procalcitonin).
  • LMWH-treated patients had more comorbidities but fewer ICU transfers and shorter hospital stays.

Conclusions:

  • Early anticoagulant treatment with LMWH may enhance clinical outcomes in COVID-19.
  • Higher doses of LMWH could potentially shorten hospital stays.
  • LMWH treatment appears beneficial for hospitalized COVID-19 patients.
Abstract

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
139
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.7K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.3K
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
129
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
108
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
111